Search research articles
Contact Us
Filters
Showing results (381-390 of 1,211) with videos related to
Page
of 122
Sort By:
The American Journal of Cardiology
|
November 26, 2008
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)
Jonathan P Piccini, Patrick M Hranitzky, Rakhi Kilaru, et al.
Journal of the American Geriatrics Society
|
September 13, 2024
Association of left atrial function with frailty: The Atherosclerosis Risk in Communities (ARIC) study
Daokun Sun, Romil R Parikh, Wendy Wang, et al.
Circulation. Heart Failure
|
January 13, 2016
Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study
Michael R Zile, Pardeep S Jhund, Catalin F Baicu, et al.
European Journal of Heart Failure
|
January 26, 2022
Natriuretic peptide-based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON-HF
Maria A Pabón, Jonathan W Cunningham, Brian L Claggett, et al.
European Heart Journal
|
October 27, 2009
Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial
Jonathan P Piccini, Min Zhang, Karen Pieper, et al.
Circulation. Heart Failure
|
March 26, 2013
Right ventricular function, pulmonary pressure estimation, and clinical outcomes in cardiac resynchronization therapy
Patricia Campbell, Madoka Takeuchi, Mikhail Bourgoun, et al.
European Journal of Heart Failure
|
April 5, 2011
Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study
Colette E Jackson, Michael R MacDonald, Mark C Petrie, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
September 17, 2025
Greater Central Adiposity Is Associated With Poorer Left Atrial Function: The Atherosclerosis Risk in Communities (ARIC) Study
Jorge L Reyes, Joseph J Decker, Romil Parikh, et al.
European Heart Journal
|
September 4, 2013
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial
Aldo P Maggioni, Stephen J Greene, Gregg C Fonarow, et al.
JACC. Heart Failure
|
October 11, 2020
Estimating the Lifetime Benefits of Treatments for Heart Failure
João Pedro Ferreira, Kieran F Docherty, Susan Stienen, et al.
Page
of 122
Search research articles
Search
Showing results (381-390 of 1,211) with videos related to
Sort By:
Page
of 122
The American Journal of Cardiology
|
November 26, 2008
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)
Jonathan P Piccini, Patrick M Hranitzky, Rakhi Kilaru, et al.
Journal of the American Geriatrics Society
|
September 13, 2024
Association of left atrial function with frailty: The Atherosclerosis Risk in Communities (ARIC) study
Daokun Sun, Romil R Parikh, Wendy Wang, et al.
Circulation. Heart Failure
|
January 13, 2016
Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study
Michael R Zile, Pardeep S Jhund, Catalin F Baicu, et al.
European Journal of Heart Failure
|
January 26, 2022
Natriuretic peptide-based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON-HF
Maria A Pabón, Jonathan W Cunningham, Brian L Claggett, et al.
European Heart Journal
|
October 27, 2009
Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial
Jonathan P Piccini, Min Zhang, Karen Pieper, et al.
Circulation. Heart Failure
|
March 26, 2013
Right ventricular function, pulmonary pressure estimation, and clinical outcomes in cardiac resynchronization therapy
Patricia Campbell, Madoka Takeuchi, Mikhail Bourgoun, et al.
European Journal of Heart Failure
|
April 5, 2011
Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study
Colette E Jackson, Michael R MacDonald, Mark C Petrie, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
September 17, 2025
Greater Central Adiposity Is Associated With Poorer Left Atrial Function: The Atherosclerosis Risk in Communities (ARIC) Study
Jorge L Reyes, Joseph J Decker, Romil Parikh, et al.
European Heart Journal
|
September 4, 2013
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial
Aldo P Maggioni, Stephen J Greene, Gregg C Fonarow, et al.
JACC. Heart Failure
|
October 11, 2020
Estimating the Lifetime Benefits of Treatments for Heart Failure
João Pedro Ferreira, Kieran F Docherty, Susan Stienen, et al.
Page
of 122